H.R.1035: Prescription Drug Price Transparency Act

About This Bill

Bill Sponsor

Bill Version

Bill Summary

Prescription Drug Price Transparency Act This bill establishes additional requirements for prescription drug plan sponsors (PDPs) under Medicare and Medicare Advantage, as well as health insurance carriers under the Federal Employees Health Benefits Program, relating to the methodology of payments to pharmacies and the use of pharmacy benefits managers (PBMs). Specifically, such PDPs and carriers must disclose specified information to...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.1035.

Bill Actions

Date Description
Feb. 7, 2019
Referred to the Subcommittee on Health.
Feb. 7, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb. 7, 2019

Introduced in the House by Doug Collins (R-Ga.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page